Franz-Werner Haas
Amministratore Delegato presso Curevac Aktiebolag
Profilo
Il dott. Franz-Werner Haas è direttore esecutivo e operativo di Curevac Aktiebolag, direttore esecutivo di CureVac AG e direttore esecutivo di CureVac NV. Il Dr. Haas è stato precedentemente impiegato come Chief Compliance Officer & VP-Operations presso Expedeon AG, General Counsel presso Sirona Dental Systems, Inc. e General Counsel presso Lion Bioscience, Inc. Si è laureato presso l'Università di Edimburgo e si è laureato presso la Universitt Saarbrcken.
Posizioni attive di Franz-Werner Haas
Società | Posizione | Inizio |
---|---|---|
Curevac Aktiebolag
Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012. | Amministratore Delegato | 04/08/2020 |
LimmaTech Biologics AG
LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Amministratore Delegato | 19/07/2023 |
Precedenti posizioni note di Franz-Werner Haas
Società | Posizione | Fine |
---|---|---|
CUREVAC N.V. | Amministratore Delegato | 31/03/2023 |
2INVEST AG | Responsabile della Conformità | 01/03/2012 |
SIRONA DENTAL SYSTEMS, INC. | Consigliere Generale | 01/05/2005 |
Lion Bioscience, Inc.
Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | Consigliere Generale | 01/12/2004 |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Amministratore Delegato | - |
Formazione di Franz-Werner Haas
The University of Edinburgh | Graduate Degree |
Universität Saarbrücken | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
2INVEST AG | Finance |
CUREVAC N.V. | Health Technology |
Aziende private | 5 |
---|---|
Lion Bioscience, Inc.
Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | Commercial Services |
Sirona Dental Systems, Inc.
Sirona Dental Systems, Inc. Medical SpecialtiesHealth Technology Sirona Dental Systems, Inc. was developing, manufacturing and marketing dental equipment. Its products include CAD/CAM restoration systems, imaging systems, treatment centers, instruments, and cabinetry. The company was founded on October 1, 1997 and was headquartered in York, PA. | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Curevac Aktiebolag
Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012. | Process Industries |
LimmaTech Biologics AG
LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Commercial Services |
- Borsa valori
- Insiders
- Franz-Werner Haas